Archive for the ‘Defective Products’ Category

San Diego Falling Merchandise Injury Attorney

Posted by Mark Blane on March 17th, 2010 under Brain Injuries, Defective Products, Premise Liability Tags: , , , ,  •  No Comments

San Diego Falling Merchandise Injury Lawyer – Information on Premise Liability Injuries

San Diego Auto Accident Law Firm Discussion: Tip for new Child Seat if you were in an Automobile Accident, San Diego Car Crash

Posted by Mark Blane on March 16th, 2010 under Automobile Accidents, Defective Products, Truck Accidents Tags: , , ,  •  No Comments

San Diego Car Accident Damages: What else are you entitled to under California law?

Class Action Against Bayer, Manufacturer of Trasylol

Posted by Mark Blane on August 11th, 2009 under Class Action Lawsuits, Defective Products, Pharmaceutical Drug Injuries Tags: , , ,  •  No Comments

There are estimates that at least 10,000 patients may unnecessarily have suffered kidney damage due to use of aprotinin (Trasylol) during heart surgery. Many patients may have been injected with Trasylol to reduce blood loss during coronary artery bypass (CABG) surgery.  Thus, the goal with using Trasylol was to stop bleeding during the heart bypass [...]

First Neurontin Trial Ends in Dismissal In U.S. District Court In Boston

Posted by Mark Blane on August 11th, 2009 under Class Action Lawsuits, Defective Products, Pharmaceutical Drug Injuries Tags: , , ,  •  No Comments

In a move that was unexpected, the first Neurontin trial has ended with a dismissal, after an anonymous donor offered to put money in a trust fund for the 10-year-old daughter of a Massachusetts woman who committed suicide two years after taking the anti-seizure drug.  Plaintiff’s lawyer Mark Lanier told Bloomberg Television that the anonymous donor was [...]

Fosamax Litigation

Posted by Mark Blane on August 11th, 2009 under Class Action Lawsuits, Defective Products, Pharmaceutical Drug Injuries Tags: , , , , ,  •  2 Comments

Fosamax® (Alendronate Sodium) is a member of a class of drugs known as “bisphosphonates.” Manufactured by Merck & Co., Fosamax was approved by the U.S. Food and Drug Administration in 1995, and is commonly used to treat patients with osteoporosis and Paget’s disease.  Fosamax and other bisphosphonates, including Aredia® and Zometa®, have been linked to [...]

Update to the Nationwide Vioxx Settlement

Posted by Mark Blane on August 11th, 2009 under Class Action Lawsuits, Defective Products, Pharmaceutical Drug Injuries Tags: , , , ,  •  4 Comments

Merck, the manufacturer of Vioxx,  has begun to make partial payments to some qualified Vioxx claimants who had heart attacks as direct result of taking their once famed drug. Of the more than 50,000 potential claims, only a few hundred were paid in August, and most other pending claims will actually be paid at a [...]

$41.5 Million Dollars To Settle Vytorin and Zetia Class Action Lawsuits

Posted by Mark Blane on August 8th, 2009 under Class Action Lawsuits, Defective Products, Pharmaceutical Drug Injuries Tags: , , , ,  •  No Comments

According to Reuters out of New York, Merck & Co, and Schering-Plough Corp will pay $41.5 million to settle class-action lawsuits over their shared cholesterol drugs Vytorin, and Zetia, the companies said on Wednesday, August 5, 2009.
The lawsuits involved allegations arising from the Enhance clinical trial, whose results released in January 2008, raised serious questions about [...]

Cancer And Tanning Beds – Is There A Causal Link?

Posted by Mark Blane on August 8th, 2009 under Defective Products Tags: , , , ,  •  No Comments

According to a new risk assessment, tanning beds are as certain to cause cancer as smoking cigarettes.  Tanning beds, also known as sun beds, and all types of ultraviolet rays are now ranked in the highest risk group by the IARC (International Agency for Resarch on Cancer).  This places the tanning beds in the same category [...]

Nutritional Supplements On The Market Get A Warning From The F.D.A.

Posted by Mark Blane on August 8th, 2009 under Defective Products Tags: , , ,  •  No Comments

Federal regulators (Food and Drug Administration) warned consumers nationwide on July 28, 2009, not to use body-building products that are sold as “Nutritional Supplements” but may contain steroids or steroidlike substances, citing reports of acute liver injury and possible failure of the kidneys.

Tren Xtreme and Mass Xtreme are among the eight supplements cited by the F.D.A. as containing [...]

Avandia Class Action Lawsuit

Posted by Mark Blane on August 1st, 2009 under Class Action Lawsuits, Defective Products, Pharmaceutical Drug Injuries Tags: , , , ,  •  No Comments

The pharmaceutical drug Avandia, also known as Rosiglitazone, is a drug that is taken for the treatment of diabetes.  Recent medical studies have shown its use increases the risk of a heart attack (myocardial infarction) by approximately 30% – 40%.  It has also been shown to increase other health risks such as:  Congestive Heart Failure; [...]